240 related articles for article (PubMed ID: 24040311)
21. Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.
Viejo-Borbolla A; Ottinger M; Brüning E; Bürger A; König R; Kati E; Sheldon JA; Schulz TF
J Virol; 2005 Nov; 79(21):13618-29. PubMed ID: 16227282
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells.
Paudel N; Sadagopan S; Balasubramanian S; Chandran B
J Virol; 2012 Feb; 86(3):1589-607. PubMed ID: 22130534
[TBL] [Abstract][Full Text] [Related]
23. Minichromosome Maintenance Proteins Cooperate with LANA during the G
Dabral P; Uppal T; Rossetto CC; Verma SC
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651368
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma-associated herpesvirus-encoded LANA can interact with the nuclear mitotic apparatus protein to regulate genome maintenance and segregation.
Si H; Verma SC; Lampson MA; Cai Q; Robertson ES
J Virol; 2008 Jul; 82(13):6734-46. PubMed ID: 18417561
[TBL] [Abstract][Full Text] [Related]
25. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.
Lu J; Verma SC; Murakami M; Cai Q; Kumar P; Xiao B; Robertson ES
J Virol; 2009 Jul; 83(14):7129-41. PubMed ID: 19439469
[TBL] [Abstract][Full Text] [Related]
26. Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats.
Verma SC; Choudhuri T; Kaul R; Robertson ES
J Virol; 2006 Mar; 80(5):2243-56. PubMed ID: 16474132
[TBL] [Abstract][Full Text] [Related]
27. Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA.
Lu F; Tsai K; Chen HS; Wikramasinghe P; Davuluri RV; Showe L; Domsic J; Marmorstein R; Lieberman PM
J Virol; 2012 May; 86(10):5752-62. PubMed ID: 22419807
[TBL] [Abstract][Full Text] [Related]
28. Kaposi's sarcoma-associated herpesvirus-encoded LANA recruits topoisomerase IIβ for latent DNA replication of the terminal repeats.
Purushothaman P; McDowell ME; McGuinness J; Salas R; Rumjahn SM; Verma SC
J Virol; 2012 Sep; 86(18):9983-94. PubMed ID: 22761383
[TBL] [Abstract][Full Text] [Related]
29. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes.
You J; Srinivasan V; Denis GV; Harrington WJ; Ballestas ME; Kaye KM; Howley PM
J Virol; 2006 Sep; 80(18):8909-19. PubMed ID: 16940503
[TBL] [Abstract][Full Text] [Related]
30. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
[TBL] [Abstract][Full Text] [Related]
31. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
32. ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin.
Stedman W; Deng Z; Lu F; Lieberman PM
J Virol; 2004 Nov; 78(22):12566-75. PubMed ID: 15507644
[TBL] [Abstract][Full Text] [Related]
33. Assay Development and High-Throughput Screening for Inhibitors of Kaposi's Sarcoma-Associated Herpesvirus N-Terminal Latency-Associated Nuclear Antigen Binding to Nucleosomes.
Beauchemin C; Moerke NJ; Faloon P; Kaye KM
J Biomol Screen; 2014 Jul; 19(6):947-58. PubMed ID: 24518064
[TBL] [Abstract][Full Text] [Related]
34. KSHV Genome Replication and Maintenance in Latency.
Ueda K
Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673
[TBL] [Abstract][Full Text] [Related]
35. Kaposi's Sarcoma Herpesvirus Genome Persistence.
Juillard F; Tan M; Li S; Kaye KM
Front Microbiol; 2016; 7():1149. PubMed ID: 27570517
[TBL] [Abstract][Full Text] [Related]
36. DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
Garber AC; Shu MA; Hu J; Renne R
J Virol; 2001 Sep; 75(17):7882-92. PubMed ID: 11483733
[TBL] [Abstract][Full Text] [Related]
37. LANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complex.
Hu J; Yang Y; Turner PC; Jain V; McIntyre LM; Renne R
PLoS Pathog; 2014 Jul; 10(7):e1004240. PubMed ID: 25033463
[TBL] [Abstract][Full Text] [Related]
38. Conservation of complex nuclear localization signals utilizing classical and non-classical nuclear import pathways in LANA homologs of KSHV and RFHV.
Cherezova L; Burnside KL; Rose TM
PLoS One; 2011 Apr; 6(4):e18920. PubMed ID: 21559489
[TBL] [Abstract][Full Text] [Related]
39. Triptolide decreases expression of latency-associated nuclear antigen 1 and reduces viral titers in Kaposi's sarcoma-associated and herpesvirus-related primary effusion lymphoma cells.
Long C; Guo W; Zhou H; Wang J; Wang H; Sun X
Int J Oncol; 2016 Apr; 48(4):1519-30. PubMed ID: 26821279
[TBL] [Abstract][Full Text] [Related]
40. Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells.
Santag S; Jäger W; Karsten CB; Kati S; Pietrek M; Steinemann D; Sarek G; Ojala PM; Schulz TF
Oncogene; 2013 Aug; 32(32):3676-85. PubMed ID: 22964633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
